All
Search
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
AbbVie
Stock
AbbVie
Company
AbbVie
Interview
AbbVie
Careers
AbbVie
Eye Care
AbbVie
Review
AbbVie
Pharma
AbbVie
Inc
AbbVie
Pharmaceuticals
AbbVie
Aktie
AbbVie
Dividend
AbbVie
Deutschland
AbbVie
Commercials
AbbVie
Ireland
AbbVie
Care
AbbVie
Allergan
AbbVie
Pharmacy Solutions
AbbVie
Pronunciation
AbbVie
CEO
AbbVie
Ludwigshafen
AbbVie
Care IBD
AbbVie
Humira
Temab
AbbVie
New Product of AbbVie Pharmaceuticals
AbbVie
Share Price
What Products Are Made in AbbVie Cork
AbbVie
North Carolina
Pharmaceutical Stock Prices
AbbVie
Commercial
Abbv Dividend
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
AbbVie
Stock
AbbVie
Company
AbbVie
Interview
AbbVie
Careers
AbbVie
Eye Care
AbbVie
Review
AbbVie
Pharma
AbbVie
Inc
AbbVie
Pharmaceuticals
AbbVie
Aktie
AbbVie
Dividend
AbbVie
Deutschland
AbbVie
Commercials
AbbVie
Ireland
AbbVie
Care
AbbVie
Allergan
AbbVie
Pharmacy Solutions
AbbVie
Pronunciation
AbbVie
CEO
AbbVie
Ludwigshafen
AbbVie
Care IBD
AbbVie
Humira
Temab
AbbVie
New Product of AbbVie Pharmaceuticals
AbbVie
Share Price
What Products Are Made in AbbVie Cork
AbbVie
North Carolina
Pharmaceutical Stock Prices
AbbVie
Commercial
Abbv Dividend
AbbVie
Stock Price
Katie Ford
Abbv Stock
AbbVie
TV
AbbVie
Deal
AbbVie
Stock Price Today
AbbVie
Skyrizi
Pronunciation of
AbbVie
My AbbVie
Account
AbbVie
Migraine
AbbVie
TV Commercials
Buy AbbVie
Stock
Katie Porter Congresswoman
1:10
AbbVie announces $63BN blockbuster immunology merger #pharma #news
47 views
3 weeks ago
YouTube
pharmaphorum media limited
1:02
Bizi biz yapan tüm renklerimizle: Biz AbbVie’liyiz!
84 views
2 weeks ago
YouTube
AbbVie Türkiye
0:44
AbbVie breakout: reclaiming the 200‑day and momentum
295 views
1 month ago
YouTube
Market Misbehavior with Dave Keller, CMT
2:16
AbbVie to Acquire Apogee Therapeutics, Expanding AD Pipeline With Zumilokibart
86 views
3 weeks ago
YouTube
Dermatology Times
0:25
AbbVie Buys Apogee for $10.9B to Replace Humira Growth
16 views
3 weeks ago
YouTube
Prism Media
1:16
Tavapadon, Dopamine Agonists, and the Expansion of Parkinson Treatment Options
694 views
2 months ago
YouTube
NeurologyLive
1:02
his Dividend Growth Stock Pays You While It Innovates | AbbVie (ABBV)
20 views
1 month ago
YouTube
Invest With Ro
1:33
2025 AbbVie Migraine Career Catalyst Award™ Winners
59 views
2 months ago
YouTube
AbbVie US
1:18
🎙️Inside “Organized Chaos” at AbbVie’s SPaRCS Group
64 views
1 month ago
YouTube
CADworks3D
1:53
AbbVie’s Earnings Beat Wall Street’s Estimates. Investors Are Still Worried
13.1K views
2 months ago
YouTube
The Wall Street Journal
1:12
Don't go through migraine alone
364 views
2 months ago
YouTube
National Headache Foundation
0:47
When migraine impacts more than work
141 views
2 months ago
YouTube
National Headache Foundation
0:50
AbbVie is not a company that needs an introduction in the pharmaceutical world
607 views
1 week ago
YouTube
Living in The Triangle with Jon Tennant
0:12
AbbVie's Tavapadon New Drug Application for Parkinson's Disease: U.S. FDA Update
291 views
3 months ago
YouTube
MCQ Pedia
0:34
AbbVie (ABBV): Pharma Stock with 50-Year Dividend Growth #shorts
944 views
5 months ago
YouTube
Simply Money
0:46
🎙️The Real Power of Hybrid Manufacturing
198 views
3 weeks ago
YouTube
CADworks3D
1:00
AbbVie Q3 2026 Dividend Announcement
271 views
4 weeks ago
YouTube
배당읽어주는주임
0:11
Abbvie $ABBV Q1 2026 Earnings Release
22 views
2 months ago
YouTube
Investing Portfolio Pathway
0:54
AbbVie Trial - Cracking Cancer Trial Series
25 views
3 weeks ago
YouTube
Cracking Cancer
1:55
AbbVie’s Earnings Beat Wall Street’s Estimates. Investors Are Still Worried
2 months ago
WSJ
See more
More like this
Feedback